Clinical Trials

A Pilot Study of Telmisartan (Micardis) for the Prevention of Acute Graft Versus Host Disease Post Allogeneic Hematopoietic Stem Cell Transplantation

Study ID
HUMC Pro00005465

NCT Number
NCT02338232 (Click on the NCT number for more information about the trial)

Research Study Number

Principle Investigator
Dr. Scott Rowley


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at

Apply Now